C van Booma-Frankfort
Overview
Explore the profile of C van Booma-Frankfort including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
230
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bakker M, Jacobs J, Welsing P, Vreugdenhil S, van Booma-Frankfort C, Linn-Rasker S, et al.
Ann Rheum Dis
. 2011 Mar;
70(6):1099-103.
PMID: 21406458
Objective: To investigate the long-term effects of the tight control (TC) and conventional (CT) methotrexate-based strategies of the Computer Assisted Management in Early Rheumatoid Arthritis trial in early rheumatoid arthritis...
2.
Verstappen S, Hoes J, ter Borg E, Bijlsma J, Blaauw A, van Albada-Kuipers G, et al.
Ann Rheum Dis
. 2006 May;
65(11):1506-11.
PMID: 16679433
Objective: To investigate the prevalence and prognostic factors of joint surgery in a large cohort of patients with rheumatoid arthritis, whose treatment, clinical and radiographic data have been assessed at...
3.
van Jaarsveld C, Jacobs J, van der Veen M, Blaauw A, Kruize A, Hofman D, et al.
Ann Rheum Dis
. 2000 Jun;
59(6):468-77.
PMID: 10834865
Objectives: To compare three therapeutic strategies using slow acting antirheumatic drugs (SAARDs) in early rheumatoid arthritis (RA), for their disease modifying properties, toxicity, and lag time until treatment effect. Methods:...
4.
van Jaarsveld C, ter Borg E, Jacobs J, Schellekens G, Gmelig-Meyling F, van Booma-Frankfort C, et al.
Clin Exp Rheumatol
. 1999 Dec;
17(6):689-97.
PMID: 10609067
Objective: To study the prognostic value of the antiperinuclear factor (APF), determined by an indirect immunofluorescence test (IIF) and a recently developed anti-citrullinated cyclic peptide (CCP) ELISA, in combination with...
5.
van der Heide A, Jacobs J, Bijlsma J, Heurkens A, van Booma-Frankfort C, van der Veen M, et al.
Ann Intern Med
. 1996 Apr;
124(8):699-707.
PMID: 8633829
Objective: To compare two therapeutic strategies for patients with recent-onset rheumatoid arthritis. Design: Open, randomized clinical trial. Setting: Outpatient clinics of six clinical centers. Patients: 238 consecutive patients with recently...
6.
van der Veen M, Dinant H, van Booma-Frankfort C, van Albada-Kuipers G, Bijlsma J
Ann Rheum Dis
. 1996 Apr;
55(4):218-23.
PMID: 8733437
Objective: To investigate whether methotrexate (MTX) has a steroid sparing effect in the treatment of polymyalgia rheumatica (PMR) and giant cell arteritis (GCA). Methods: We carried out a randomised double...